• Sector
    • Challenges
    • Objectives
    • Strengths and operating rules
  • Organization
    • Expertises & plateforms
    • Members
      • SMEs
      • Pharmaceutical companies
      • Academic partners
    • Institutional partners
    • Partnership
  • Products/Services
  • News/Events
    • News
    • Events
  • Contact
  • Extranet
English
  • French

News

  • Home
  • News
14/11/2016
Discover and Share the Newsletter IMODI #2 – November 2016
Publié par Webmaster le 14/11/2016
Catégories
  • News
  • Newsletter

Discover and Share the Newsletter IMODI #2 – November 2016

Aimez-vous ?0
En savoir plus
09/11/2016
Oncomedics
Publié par Webmaster le 09/11/2016
Catégories
  • News

Oncomedics FOCUS: Personnalizing the cancer treatments

Aimez-vous ?1
En savoir plus
09/11/2016
Publié par Webmaster le 09/11/2016
Catégories
  • News

Agreement for Oncodesign’s acquisition of GSK’s Research Centre

Aimez-vous ?1
En savoir plus
26/10/2016
2D primary culture from non-small cell lung cancer PDX in Oncomedics’ proprietary defined medium.
Publié par Webmaster le 26/10/2016
Catégories
  • News

2D/3D EX vivo Assays: A PDX-based platform for ex vivo evaluating/screening of novel anti-cancer compounds

Aimez-vous ?1
En savoir plus
13/09/2016
ESBB Vienna 2016
Publié par Webmaster le 13/09/2016
Catégories
  • Events
  • News

Join ModulBio at the ESBB Vienna 2016, booth 45

Aimez-vous ?1
En savoir plus
12
Next

Imodi_Cancer
A French consortium to develop new experimental models of cancer. Modelizing the diversity of cancers for effective treatments tailored to each patient.

Latest news

  • Discover and Share the Newsletter IMODI #2 – November 2016
    Discover and Share the Newsletter IMODI #2 – November 2016
    14/11/2016
  • Oncomedics
    Oncomedics FOCUS: Personnalizing the cancer treatments
    09/11/2016

Quick access

  • The IMODI Sector
  • Organization
  • Products & Services
  • News & Events
  • Contact us
Powered by Modul-Bio - © IMODI - All rights reserved

    Your name (required)

    Your email (required)

    Company

    Subject

    Your message

    This website uses cookies to collect anonymous statistical indicators. We'll assume you're ok with this, but you can opt-out if you wish.Accept
    Privacy & Cookies Policy

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Toujours activé

    Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

    Non-necessary

    Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

    Enregistrer & accepter